SCHEMBL4132060

SCHEMBL4132060

CCCN(CCC)c1nc2c(-c3ccccc3C)nn(C)c2c(=O)[nH]1

nearest known ligand 0.43

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 7/20 0.43
CRHR1 P34998 8/20 0.42
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
PDE1A P54750 1/20 0.41
PDE1B Q01064 1/20 0.41
KMT2A Q03164 1/20 0.41
PDE1C Q14123 1/20 0.41
PDE3B Q13370 2/20 0.39
PDE3A Q14432 2/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4120264 0.88 CRHR1 (0.48) PDE5ACRHR1MEN1ALDH1A1HPGD
SCHEMBL4000244 0.86 PDE5A (0.46) PDE5ACRHR1MEN1ALDH1A1HPGD
SCHEMBL4127685 0.85 PDE5A (0.51) PDE5ACRHR1MEN1ALDH1A1HPGD
SCHEMBL4138719 0.82 PDE5A (0.39) PDE5ACRHR1MEN1ALDH1A1HPGD
SCHEMBL4143420 0.80 CRHR1 (0.42) PDE5ACRHR1ALDH1A1KDM4E
SCHEMBL4136240 0.79 CRHR1 (0.39) PDE5ACRHR1MEN1ALDH1A1HPGD
SCHEMBL4140332 0.79 CRHR1 (0.41) PDE5ACRHR1
SCHEMBL4123921 0.79 PDE5A (0.42) PDE5ACRHR1
SCHEMBL4130996 0.78 PDE5A (0.41) PDE5ACRHR1
SCHEMBL4126045 0.78 PDE5A (0.41) PDE5ACRHR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009071705-A1 PYRAZOLEPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS NV (BE) 2009-06-11 WO claimed
WO-2009071705-A1 PYRAZOLEPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS NV (BE) 2009-06-11 WO disclosed
WO-2009071705-A1 PYRAZOLEPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS NV (BE) 2009-06-11 WO disclosed